Close
CDMO Safety Testing 2026
Novotech

Schreiner MediPharm Equips Cap-Lock Security Label with RFID Technology

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.
- Advertisement -

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a special RFID inlay. Developed to help hospitals expand digitization initiatives, the label-and-cap security concept for prefilled syringes now also enables automated inventory and supply chain management, as well as digital first-opening indication. In doing so, the new Cap-Lock plus RFID solution offers efficient and reliable product authentication and enhanced patient safety.

Equipping syringes containing liquid medications with RFID-Labels poses a challenge, as both the container material and the composition of the liquid may impair reading of a UHF RFID-Label. Flag labels protruding from the container are frequently used for this purpose; however, these typically require additional space, are prone to being torn off and must be applied manually.

With Cap-Lock plus RFID, the RFID chip is integrated in the label. Cap-Lock is a combination of a cap adapter and label. The adapter is placed on top of the syringeโ€™s primary closure and interlinked with it to equalize the diameter differences of the syringe body and closure. The label wraps around the syringe body and cap adapter andโ€”once openedโ€”provides irreversible tamper evidence due to an integrated perforation.

The RFID inlay is located in the upper part of the label at the level of the cap. Thus, it largely sits outside the liquid-filled area and enables reliable long-range reading. Due to the RFID functionality, digital first-opening evidence is now possible in addition to the previous, purely visual first-opening indication provided by the destroyed label. The RFID-Label can be automatically processed as part of the primary containerโ€™s normal labeling workflow.

For live monitoring and control of the logistic flow of materials and products in automated inventory and supply chain management, the data of syringes equipped with RFID-Labels can be automatically captured at various stations. As a result of reading the picked and placed products, current inventory information is consistently stored in a database. Additionally, integrity, first-opening or tampering with containers can be digitally monitored by means of the purpose-developed RFID-Sensor-Label.

In medication management, data stored on the RFID-Labelsโ€”such as product name, manufacturer, batch number and expiration dateโ€”is read automatically either individually or in bulk using simple handheld or specialty readers, and matched with a database. This enables exact tracking of inventories and provides transparency regarding medicines that are missing or approaching their expiration date. This helps protect patients against potential medication errors.

About Schreiner MediPharm

Based in the Munich area of Germany, Schreiner MediPharm is a global leader in the development and manufacture of innovative specialty labels with value-added benefits that have set the standard in the healthcare and pharmaceutical industries. Schreiner MediPharmโ€™s expertise is based on over 65 years of experience. The family-owned company provides specialty labels and label printing services to the biggest names in the healthcare market around the world.

Latest stories

Related stories

BeOne Signs $2B Trispecific Antibody Deal with Huahui Health

BeOne Medicines has entered into a high-value agreement with...

Quantum Machine Learning in Pharma Research Growth

The convergence of artificial intelligence and quantum processing is opening new avenues for rapid discovery and innovation within the life sciences. By utilizing advanced mathematical models that operate across multi-dimensional datasets, researchers can now identify complex biological patterns and predict molecular behaviors with a speed that surpasses traditional computational methods. This transformation is accelerating the development of novel therapies and providing deeper insights into disease mechanisms, fundamentally altering the trajectory of pharmaceutical research and development.

Quantum Sensors Enabling Advanced Drug Diagnostics

The landscape of medical diagnostics is being reshaped by the introduction of sensing technologies that operate with atomic-level sensitivity. By providing high-fidelity measurements and real-time data, these tools allow for the detection of subtle biological changes and chemical markers that were previously invisible to conventional equipment. This advancement is enhancing the precision of drug testing and clinical monitoring, leading to earlier disease detection and more effective therapeutic interventions across the global healthcare spectrum.

Quantum Computing Optimizing Pharma Supply Chains

The global distribution of pharmaceutical products is facing unprecedented challenges that demand a new level of logistical precision and resilience. By utilizing advanced analytical models, companies can now navigate complex international networks with greater efficiency, ensuring that temperature-sensitive medicines and life-saving therapies reach their destinations without delay. This evolution toward a more intelligent and responsive supply chain is critical for maintaining public health and responding effectively to emerging medical needs on a global scale.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป